FDA
-
-
-
-
-
-
-
Ironwood Survey Findings at DDW 2026 Underscore Need for Therapies that Address Multiple Dimensions of Total Parenteral Nutrition (TPN) Burden in Short Bowel Syndrome (SBS)
-
-
-
-
-
-
-
FDA approves Ironwood's Linzess for pediatric IBS-C patients
-
-
-
-
-
-
-
Jefferies Downgrades Ironwood Pharmaceuticals (IRWD) to Hold
-
-
-
-
-
-
-
Ironwood Pharmaceuticals Reports Third Quarter 2024 Results
-
-
-
-
-
-
-
Ironwood Pharma (IRWD) Reports Positive Topline Results from Global Phase III Trial of Once-Weekly Apraglutide
-
-
-
-
-
-
-
Ironwood Pharma (IRWD) Completes Merger With VectivBio
-
-
-
-
-
-
-
Ironwood and VectivBio Announce the Completion of the Tender Offer for VectivBio Shares
-
328,143 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

